Gayn Erickson - 31 Jan 2023 Form 4 Insider Report for AEHR TEST SYSTEMS (AEHR)

Role
President and CEO, Director
Signature
/s/ Kenneth B. Spink, Attorney-in-fact
Issuer symbol
AEHR
Transactions as of
31 Jan 2023
Net transactions value
+$319,143
Form type
4
Filing time
02 Feb 2023, 15:01:29 UTC
Previous filing
26 Jan 2023
Next filing
27 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AEHR Common Stock Options Exercise $93,754 +23,856 +4.8% $3.93* 519,109 31 Jan 2023 Direct
transaction AEHR Common Stock Options Exercise $194,393 +80,997 +16% $2.40* 600,106 31 Jan 2023 Direct
transaction AEHR Common Stock Options Exercise $30,996 +18,958 +3.2% $1.64* 619,064 31 Jan 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AEHR Incentive Stock Option (right to buy) Options Exercise $0 -18,958 -54% $0.000000 16,251 31 Jan 2023 Common Stock 18,958 $1.64 Direct F2
transaction AEHR Incentive Stock Option (right to buy) Options Exercise $0 -80,997 -100% $0.000000* 0 31 Jan 2023 Common Stock 80,997 $2.40 Direct F2
transaction AEHR Incentive Stock Option (right to buy) Options Exercise $0 -23,856 -100% $0.000000* 0 31 Jan 2023 Common Stock 23,856 $3.93 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares.
F2 One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter.

Remarks:

Ex. 24 - Power of Attorney